绒毛膜癌:一种罕见生殖细胞肿瘤的诊断、治疗和管理。更新回顾。

IF 2 4区 医学 Q3 ONCOLOGY
Tumori Pub Date : 2026-06-01 Epub Date: 2026-02-23 DOI:10.1177/03008916251408266
Pierantoni Francesco, Fabiana Caliciotti, Selma Ahcene Djaballah, Eleonora Lai, Davide Bimbatti, Silvia Stragliotto, Ilaria Zampiva, Melissa Ballestrin, Chiara Pittarello, Salim Jubran, Greta Pretto, Elisa Erbetta, Anna Milani, Umberto Basso, Marco Maruzzo
{"title":"绒毛膜癌:一种罕见生殖细胞肿瘤的诊断、治疗和管理。更新回顾。","authors":"Pierantoni Francesco, Fabiana Caliciotti, Selma Ahcene Djaballah, Eleonora Lai, Davide Bimbatti, Silvia Stragliotto, Ilaria Zampiva, Melissa Ballestrin, Chiara Pittarello, Salim Jubran, Greta Pretto, Elisa Erbetta, Anna Milani, Umberto Basso, Marco Maruzzo","doi":"10.1177/03008916251408266","DOIUrl":null,"url":null,"abstract":"<p><p>Choriocarcinoma is a malignant neoplasia which develops from trophoblastic cells. In males it is rare and often associated with other non-seminomatous germ cell tumours of the testis. Choriocarcinoma often presents with metastatic disease and elevated βHCG levels. Usually, patients' symptoms are associated with the different metastatic sites and they can be severe or even life-threatening. Moreover, choriocarcinoma is chemosensitive and the administration of chemotherapy with curative intent may lead to tumour-lysis syndrome and the more specific choriocarcinoma syndrome (CS). Therefore, the treatment of metastatic choriocarcinoma is complex, involving both oncological therapy and the management of acute complications. This review explores choriocarcinoma in males, focusing on its clinical presentation, pathogenetic mechanisms, and treatment options, including investigational therapies. Additionally, we aim to highlight the severe complications of CS and discuss its management strategies.</p>","PeriodicalId":23349,"journal":{"name":"Tumori","volume":" ","pages":"192-199"},"PeriodicalIF":2.0000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13250271/pdf/","citationCount":"0","resultStr":"{\"title\":\"Choriocarcinoma: Diagnosis, treatment and management of a rare germ cell tumour. An update review.\",\"authors\":\"Pierantoni Francesco, Fabiana Caliciotti, Selma Ahcene Djaballah, Eleonora Lai, Davide Bimbatti, Silvia Stragliotto, Ilaria Zampiva, Melissa Ballestrin, Chiara Pittarello, Salim Jubran, Greta Pretto, Elisa Erbetta, Anna Milani, Umberto Basso, Marco Maruzzo\",\"doi\":\"10.1177/03008916251408266\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Choriocarcinoma is a malignant neoplasia which develops from trophoblastic cells. In males it is rare and often associated with other non-seminomatous germ cell tumours of the testis. Choriocarcinoma often presents with metastatic disease and elevated βHCG levels. Usually, patients' symptoms are associated with the different metastatic sites and they can be severe or even life-threatening. Moreover, choriocarcinoma is chemosensitive and the administration of chemotherapy with curative intent may lead to tumour-lysis syndrome and the more specific choriocarcinoma syndrome (CS). Therefore, the treatment of metastatic choriocarcinoma is complex, involving both oncological therapy and the management of acute complications. This review explores choriocarcinoma in males, focusing on its clinical presentation, pathogenetic mechanisms, and treatment options, including investigational therapies. Additionally, we aim to highlight the severe complications of CS and discuss its management strategies.</p>\",\"PeriodicalId\":23349,\"journal\":{\"name\":\"Tumori\",\"volume\":\" \",\"pages\":\"192-199\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2026-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13250271/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tumori\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/03008916251408266\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/2/23 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumori","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/03008916251408266","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/23 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

绒毛膜癌是一种由滋养细胞发展而来的恶性肿瘤。在男性中,它是罕见的,通常与睾丸的其他非半瘤性生殖细胞肿瘤有关。绒毛膜癌通常表现为转移性疾病和βHCG水平升高。通常,患者的症状与不同的转移部位有关,可能很严重,甚至危及生命。此外,绒毛膜癌具有化疗敏感性,以治疗为目的的化疗可能导致肿瘤溶解综合征和更特异性的绒毛膜癌综合征(CS)。因此,转移性绒毛膜癌的治疗是复杂的,包括肿瘤治疗和急性并发症的管理。本文综述了男性绒毛膜癌的临床表现、发病机制和治疗方案,包括研究性治疗。此外,我们旨在强调CS的严重并发症,并讨论其管理策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Choriocarcinoma: Diagnosis, treatment and management of a rare germ cell tumour. An update review.

Choriocarcinoma is a malignant neoplasia which develops from trophoblastic cells. In males it is rare and often associated with other non-seminomatous germ cell tumours of the testis. Choriocarcinoma often presents with metastatic disease and elevated βHCG levels. Usually, patients' symptoms are associated with the different metastatic sites and they can be severe or even life-threatening. Moreover, choriocarcinoma is chemosensitive and the administration of chemotherapy with curative intent may lead to tumour-lysis syndrome and the more specific choriocarcinoma syndrome (CS). Therefore, the treatment of metastatic choriocarcinoma is complex, involving both oncological therapy and the management of acute complications. This review explores choriocarcinoma in males, focusing on its clinical presentation, pathogenetic mechanisms, and treatment options, including investigational therapies. Additionally, we aim to highlight the severe complications of CS and discuss its management strategies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Tumori
Tumori 医学-肿瘤学
CiteScore
3.50
自引率
0.00%
发文量
58
审稿时长
6 months
期刊介绍: Tumori Journal covers all aspects of cancer science and clinical practice with a strong focus on prevention, translational medicine and clinically relevant reports. We invite the publication of randomized trials and reports on large, consecutive patient series that investigate the real impact of new techniques, drugs and devices inday-to-day clinical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书